Exploratory/Developmental Research on Guillain Barre Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (R21 - Clinical Trial Not Allowed)
$3,000,000
HHS-NIH11
POSTED: 11/13/2024
UPDATED: 09/09/2025
DUE: 11/14/2025
The purpose of this initiative are to accelerate research leading to improved understanding and treatments for Guillain Barre Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP...
Digital Health Technology Derived Biomarkers and Outcome Assessments for Remote Monitoring and Endpoint Development (UG3/UH3 - Clinical Trial Optional)
HHS-NIH11
POSTED: 11/13/2024
UPDATED: 12/13/2024
DUE: 06/22/2026
The purpose of this proposed Notice of Funding Announcement (NOFO) is to support development of biomarkers or clinical outcomes derived from digital health technology (DHT) for use in clinical trials ...
NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 11/12/2024
UPDATED: 11/12/2024
DUE: 01/07/2028
The purpose of the NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22) program is to facilitate transition of highly qualified dentists from NIH Intramural postdoctoral ...
Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)
HHS-NIH11
POSTED: 11/12/2024
UPDATED: 11/12/2024
DUE: 09/07/2028
This funding opportunity announcement (FOA) encourages the submission of exploratory/developmental research grant (R21) applications that focus on different aspects of cancer control by modifying beha...
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
$499,999
HHS-NIH11
POSTED: 11/12/2024
UPDATED: 11/12/2024
DUE: 01/07/2027
Through this Notice of Funding Opportunity, the National Cancer Institute (NCI) seeks research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials focused o...
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
HHS-NIH11
POSTED: 11/12/2024
UPDATED: 11/12/2024
DUE: 01/07/2027
Through this notice of funding opportunity (NOFO), the National Cancer Institute (NCI) invites applications for support of investigator-initiated clinical trials that have the potential to reduce the ...
NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)
HHS-NIH11
POSTED: 11/12/2024
UPDATED: 11/12/2024
DUE: 09/05/2027
This announcement encourages small business applications for exploratory clinical trials of investigational agents (drugs, biologics, surgical therapies or devices) that may contribute to the justific...
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required)
HHS-NIH11
POSTED: 11/08/2023
UPDATED: 11/09/2023
DUE: 10/14/2026
The purpose of the NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00) program is to increase and maintain a strong cohort of new and talented, NCI-supported, independ...
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)
HHS-NIH11
POSTED: 11/08/2023
UPDATED: 11/09/2023
DUE: 10/14/2026
The purpose of the NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00) program is to increase and maintain a strong cohort of new and talented, NCI-supported, independ...
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 11/08/2023
UPDATED: 11/09/2023
DUE: 10/14/2026
The purpose of the NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00) program is to increase and maintain a strong cohort of new and talented, NCI-supported, independ...